Management of Hepatitis C Virus in the New Era:
Small Molecules Bring Big Changes

Quick Links: To access program details, click on any link listed below. To return to this page, click on the back button of your browser.

• Half-Day Intensive Viral Hepatitis Workshops
• Full-Day Viral Hepatitis Course
  

As part of our evolving mission to address viruses in addition to HIV, the IAS–USA has created both a full-day CME course and an intensive new workshop series to focus on new research in preparation for emerging management strategies in viral hepatitis infections and the opportunity to learn from experts, discuss your own clinical cases, and contribute your own expertise.

For more information, please click on the links below or contact the IAS–USA at
info "at" iasusa.org or 415-544-9400.

An IAS–USA State-Of-The-Art Clinical Conference
Management of Hepatitis C Virus in the New Era: Small Molecules Bring Big Changes

This full-day course will focus on hepatitis C virus (HCV) infection. Rapid advances in treatment are expected with the introduction of direct-acting antivirals (DAAs) to the HCV treatment paradigm. Studies project a large increase in the number of patients requiring HCV treatment in the near future, and we are entering an exciting new era in HCV care. We invite clinicians who are expert in the complexities of HIV antiretroviral management to join their hepatology and gastroenterology colleagues in providing care for these patients.

New York, NY
Thursday, June 7, 2012
New York Marriott Marquis
Click here for more information
To register online, please click here.

2012 Half-Day Intensive Viral Hepatitis Workshops

These intensive half-day workshops are limited to 35 clinicians (physicians, physician assistants, nurse practitioners). These small-group interactive workshops are designed to improve clinical management of people infected with HCV.

The workshops will address the following issues:

• Emerging data on investigational new drugs for HCV and classes that will be available to clinicians

• Application of combination chemotherapy in HCV infection

• Management of patients with HCV/HIV coinfection

  
  

New York, NY
Monday, March 19, 2012
12:30 PM – 5:30 PM
New York Marriott Marquis
Registration is full. Contact the IAS–USA for waitlist.

Los Angeles, CA
Thursday, March 29, 2012
12:30 PM – 5:30 PM
Sheraton Los Angeles
Registration is full. Contact the IAS–USA for waitlist.

San Francisco, CA
Tuesday, April 17, 2012
8:30 AM – 1:30 PM
South San Francisco Conference Center
Transportation Options
Registration is full. Contact the IAS–USA for waitlist.

Atlanta, GA
Thursday, April 26, 2012
12:30 PM – 5:30 PM
Cobb Galleria Centre
Registration is full. Contact the IAS–USA for waitlist.

Chicago, IL
Tuesday, May 15, 2012
8:30 AM – 1:30 PM
Marriott Chicago Downtown

Washington, DC
Monday, June 18, 2012
12:30 PM – 5:30 PM
Hyatt Regency Crystal City

Click here to download a workshop registration form.
To register online, please click here.

Click here to view past workshops (from spring and fall 2011)

GRANT SUPPORT

The IAS–USA has requested grants from commercial companies with competing products. To date, the following companies have made commitments:

PLATINUM SUPPORTER:
Vertex Pharmaceuticals

GOLD SUPPORTERS:
Abbott Laboratories
Gilead Sciences, Inc
Merck & Co, Inc

SILVER SUPPORTER:
Janssen Therapeutics

Please Note: Adobe Acrobat Reader 4.0 or higher needed to view PDF files.